AZURE BIOSYSTEMS INC

Azure Biosystems Inc. specializes in the design, manufacturing, and supply of advanced analytical laboratory instrumentation, with a primary focus on molecular imaging and detection systems. Their core capabilities center on high-sensitivity gel and blot imaging platforms, real-time PCR systems, and precision biomolecular analyzers such as the Azure 300, Azure 600, and Sapphire FL platforms. The company delivers mission-critical equipment used in genomics, proteomics, and life sciences research, integrating optical detection, fluorescence quantification, and automated data analysis workflows. Their technical expertise lies in optical sensor calibration, low-noise imaging architecture, and FDA-cleared diagnostic-ready hardware, enabling reproducible results in regulated environments. Differentiators include proprietary imaging algorithms, ruggedized instrument design for field and lab use, and seamless integration with downstream data management systems. Azure Biosystems Inc. maintains a strong, recurring relationship with the Department of Health and Human Services, supplying imaging and molecular analysis systems to NIH institutes such as NICHD for biomedical research. They also serve the Department of Defense with specialized laboratory instrumentation for biological threat detection and field-deployable diagnostics, and have delivered equipment to the Department of Agriculture for pathogen and agricultural sample analysis. Their agency engagements reflect long-term procurement patterns tied to research infrastructure modernization and equipment replacement cycles. The company operates primarily under NAICS 334516, which encompasses the manufacturing of analytical laboratory instruments used in life sciences, clinical diagnostics, and environmental testing. Their market positioning is as a niche supplier of high-performance imaging systems for government-funded research and public health applications, distinct from broad-spectrum lab equipment vendors. As a small business structured as a 2L entity based in Dublin, California, Azure Biosystems Inc. maintains a focused presence in the federal life sciences procurement market. While currently holding no formal government certifications, their consistent delivery of precision instrumentation to high-regulation agencies underscores their adherence to quality and compliance standards required in federal research environments.